Ryanodine Receptor - A Novel Therapeutic Target in Heart Disease

E-ISSN： 2212-3962|2|2|110-118

ISSN： 1574-8901

Source： Recent Patents on Cardiovascular Drug Discovery, Vol.2, Iss.2, 2007-06, pp. : 110-118

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

I_f channels as a therapeutic target in heart disease

By Suffredini Silvia Mugelli Alessandro Cerbai Elisabetta

Future Cardiology, Vol. 3, Iss. 6, 2007-11 ,pp. : 657-666

Future Medicine

Access to resources Recommend Favorite

The Ryanodine Receptor: Cause or Consequence of Diabetic Heart Failure?

By Eisner D.A. Díaz M.E. O»Neill S.C. Trafford A.W.

Journal of Molecular and Cellular Cardiology, Vol. 32, Iss. 7, 2000-07 ,pp. : 1377-1378

Academic Press

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor γ as a Novel Therapeutic Target in Asthma

By Park Seoung Ju Lee Yong Chul

Journal of Asthma, Vol. 45, Iss. 1, 2008-01 ,pp. : 1-8

Informa Healthcare

Access to resources Recommend Favorite

The P2Y₁₂ receptor as a therapeutic target in cardiovascular disease

By Storey R. F.

Platelets, Vol. 12, Iss. 4, 2001-06 ,pp. : 197-209

Informa Healthcare

Access to resources Recommend Favorite

Adenosine A₃ Receptor: A promising therapeutic target in cardiovascular disease

Current Cardiology Reviews, Vol. 12, Iss. 1, 2016-02 ,pp. : 18-26

Bentham Science Publishers

Access to resources Recommend Favorite